EPIDEMIOLOGY AND RISK FACTORS FOR EXTRAHEPATIC CHOLANGIOCARCINOMA IN THE ABSENCE OF VIRAL HEPATITIS AND PRIMARY SCLEROSING CHOLANGITIS

被引：0

作者：

Abdelhakeem, Ahmed ^{[1
]}

Hatia, Rikita ^{[2
]}

Eluri, Madulika ^{[3
]}

Shalaby, Ahmed ^{[4
]}

Karatas, Elif ^{[5
]}

Shalaby, Akram ^{[6
]}

Jalal, Prasun K. ^{[7
]}

Shroff, Rachna T. ^{[8
]}

Hawk, Ernest ^{[9
]}

Li, Donghui ^{[10
]}

Javle, Milind ^{[10
]}

Hassan, Manal M. ^{[2
]}

机构：

[1] Baptist Hosp Southeast Texas, Dept Internal Med, Beaumont, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Heamtol Oncol Fellowship, Houston, TX USA

[4] Robert Wood Johnson Univ Hosp, Dept Radiat Oncol, New Brunswick, NJ USA

[5] Jacobi Med Ctr, Dept Internal Med, New York, NY USA

[6] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA

[7] Baylor Coll Med, Div Gastroenterol & Hepatol, Houston, TX USA

[8] Univ Arizona, Div Hematol Oncol, Coll Med, Tucson, AZ USA

[9] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent Populat Sci, Houston, TX USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4427

引用

页码：S1325 / S1326

页数：2

共 50 条

[41] ACTIVATION OF COAGULATION FACTORS AND IMPAIRED FIBRINOLYSIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND CHOLANGIOCARCINOMA
Fabris, Luca
Venturin, Camilla
Frion-Herrera, Yahima
Cadamuro, Massimiliano
Mescoli, Claudia
Cillo, Umberto
Gringeri, Enrico
Campello, Elena
Strazzabosco, Mario
Calvisi, Diego
Cigliano, Antonio
Simioni, Paolo
HEPATOLOGY, 2024, 80
[42] Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
Schrumpf, E
Boberg, KM
Autoimmune Liver Disease, 2005, 142 : 203 - 207
[43] Cholangiocarcinoma in primary sclerosing cholangitis: Who is at risk and how do we screen?
de Groen, PC
HEPATOLOGY, 2000, 31 (01) : 247 - 248
[44] Novel machine learning algorithm for risk prediction of cholangiocarcinoma in primary sclerosing cholangitis
Wunsch, Ewa
Horecki, Marcin
Milkiewicz, Malgorzata
Kruk, Beata
Fischer, Katarzyna
Winikajtis-Burzynska, Agnieszka
Norman, Gary
Roggenbuck, Dirk
Milkiewicz, Piotr
JOURNAL OF HEPATOLOGY, 2024, 80 : S308 - S308
[45] Biliary dysplasia in primary sclerosing cholangitis as a marker of increased risk of cholangiocarcinoma.
Fleming, KA
Clausen, OP
Glauman, H
Bergquist, A
Smith, D
HEPATOLOGY, 1998, 28 (04) : 446A - 446A
[46] Mayo Risk Score is not predictive of Cholangiocarcinoma associated with Primary Sclerosing Cholangitis.
Olivera, MA
McCashland, TM
Ruby, L
Rouillard, S
Somberg, K
Reddy, R
GASTROENTEROLOGY, 1998, 114 (04) : A1316 - A1316
[47] Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
Fung, Brian M.
Lindor, Keith D.
Tabibian, James H.
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (06) : 659 - 671
[48] Cancer risk in primary sclerosing cholangitis: Epidemiology,prevention, and surveillance strategies
Brian M Fung
Keith D Lindor
James H Tabibian
World Journal of Gastroenterology, 2019, (06) : 659 - 671
[49] AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, Christopher L.
Arrive, Lionel
Bergquist, Annika
Deneau, Mark
Forman, Lisa
Ilyas, Sumera I.
Lunsford, Keri E.
Martinez, Mercedes
Sapisochin, Gonzalo
Shroff, Rachna
Tabibian, James H.
Assis, David N.
HEPATOLOGY, 2023, 77 (02) : 659 - 702
[50] Primary Sclerosing Cholangitis and Cholangiocarcinoma: Pathogenesis and Modes of Diagnostics
Ehlken, Hanno
Schramm, Christoph
DIGESTIVE DISEASES, 2013, 31 (01) : 118 - 125

← 1 2 3 4 5 →